The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
News|Articles|September 5, 2013
BioReliance Opens Clearance Services Laboratories in US
Author(s)Pharmaceutical Technology Editors
BioReliance opens Clearance Services Laboratories in Maryland for downstream bioprocessing studies.
Advertisement
BioReliance
, SAFC’s biologics and early-development services business, has opened a Clearance Services facility in Rockville, MD.
This facility, commissioned on Aug. 1, 2013, doubles the amount of space available to clients to conduct downstream bioprocessing studies.
The Rockville facility features four clearance suites with modular layouts that allow for customized laboratory setups. The investment completes BioReliance’s global facility upgrade plan. The Stirling, Scotland, Clearance Services laboratories were renovated and expanded in 2011.
Source:
BioReliance
Advertisement
Related to this article
Subathra Ramamoorthy, Veranova, on when to escalate to structural elucidation and pair orthogonal techniques when characterizing an impurity.
Manish Baviskar, Hubot CDMO, on ALCOA++ data integrity, model version change control, continuous monitoring, and human sign-off.
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Manish Baviskar, Hubot CDMO, explains which AI skills validation engineers need first and why AI model updates must go through GMP change control.
Ron Filler, Drug Development Consultants, explains how USP's 1074 revision brings human-relevant safety science to formulators and excipient makers.
Nitin Kumar Swarnakar, PhD, global application lab manager at BASF, talks about spray drying for drying amorphous solid dispersions and Raman spectroscopy’s role as a quantitative analytical tool.
Aleksandra Zuraw, senior veterinary pathologist at Charles River, discusses how chain of custody, good laboratory practice, quality control, and validation are applied to digital pathology data used in drug development.
Advertisement
Advertisement